Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population

Clinical trials in trauma populations are exploring the use of clinical cellular therapeutics (CCTs) like human mesenchymal stromal cells (MSC) and mononuclear cells (MNC). Recent studies demonstrate a procoagulant effect of these CCTs related to their expression of tissue factor (TF). We sought to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Stem Cells Transl Med
Main Authors: George, Mitchell J., Prabhakara, Karthik, Toledano‐Furman, Naama E., Gill, Brijesh S., Wade, Charles E., Cotton, Bryan A., Cap, Andrew P., Olson, Scott D., Cox, Charles S.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Standards, Protocols, Policies, and Regulations for Cell‐based Therapies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7103617/
https://ncbi.nlm.nih.gov/pubmed/31903737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.19-0206
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki